Alzheimer's Cases Surpass 7 Million, Early Risks Noted

The number of Americans aged 65 and older living with Alzheimer's disease has surpassed 7 million, according to the 2025 Alzheimer's Association report. South Carolina is highlighted for its particularly high rates and significant investments in biomarker research and blood tests to improve diagnostics. New research indicates that Alzheimer's risk factors and biomarkers may affect cognitive function as early as the 20s and 30s, underlining the importance of early prevention. Digital cognitive assessments in primary care have shown potential for early identification but are not yet consistently implemented. Public surveys demonstrate strong interest in early biomarker testing and treatment, even before symptoms appear, as families grapple with the emotional and financial effects of the disease. However, proposed federal research funding cuts threaten to slow advancements in Alzheimer's understanding and treatment.